• Report details
  • 3 Figures
  • 28 Tables
  • Chapter 1: Introduction
    • Report Coverage
    • Methodology
    • Sources of Information
  • Chapter 2: Executive Summary
  • Chapter 3: Market Environment & Analysis
    • Overview
      • Demographic Patterns
      • World Healthcare Trends
    • Biomarker Technologies
    • Biomarker Market Analysis
      • Biomarker Products
      • Geographical Markets
  • Chapter 4: Infectious Disease Biomarkers
    • Overview
    • Infectious Disease Biomarker Technologies
    • COVID-19 Biomarkers
    • Respiratory Diseases
      • Pneumonia
      • Influenza
      • Group A Streptococcus Infections
      • Tuberculosis
      • Other Respiratory Infections
    • Healthcare-Associate​d Infections (HAIs)
      • Clostridioides difficile (c. diff)
      • Sepsis
      • Staphylococcus aureus
      • Enterococcus
      • Other Healthcare-Associate​d Infections
    • Hepatitis
      • Types of Hepatitis
      • Hepatitis Biomarkers
      • Commercial Hepatitis Tests
    • HIV
      • Overview
      • Statistical Trends
      • Biomarker-Based HIV Tests
      • Commercial HIV Tests
    • Sexually Transmitted Diseases (STDs)
      • Human Papillomavirus (HPV)
      • Chlamydia/Gonorrhea (CT/NG)
      • Trichomoniasis
      • Herpes Simplex Virus (HSV-1 & HSV-2)
      • Other Sexually Transmitted Diseases
    • TORCH
    • Other Infectious Diseases
      • Malaria
      • Lyme Disease
      • E. coli
      • H. pylori
      • Dengue
      • All Other Disease
  • Chapter 5: Cancer Biomarkers
    • Overview
    • Types of Cancer Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 6: Cardiovascular Biomarkers
    • Overview
    • Key Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 7: Clinical Chemistry Biomarkers
    • Overview
    • Blood Gases & Electrolytes
    • Urinanalysis
    • Workstation Immunoassay Tests
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 8: Neurological Biomarkers
    • Overview
    • Key Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 9: Autoimmune Biomarkers
    • Overview
    • Key Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 10: Other Biomarkers
    • Overview
    • Diabetes & Metabolic Biomarkers
    • Fertility & Pregnancy Biomarkers
    • Kidney Disorders
    • Inherited Diseases
      • Cystic Fibrosis
      • Down Syndrome
      • Sickle Cell Disease
      • Gaucher Disease
      • Familial Hypercholesterolemia
      • Muscular Dystrophy
      • Hemophilia
      • Von Willebrand Disease
      • Neurofibromatosis
      • Polycystic Kidney Disease
      • Spinal Muscle Atrophy
      • Klinefelter Syndrome
      • Canavan disease
      • Cerebral Palsy
      • Angelman Syndrome (AS)
      • Other Inherited Diseases
    • Thyroid Conditions
    • All Other Biomarkers
      • Bone Disease Biomarkers
      • Gastrointestinal Biomarkers
      • Respiratory Biomarkers
  • Chapter 11: Company Profiles
    • Roche Diagnostics (Basel, Switzerland)
      • Molecular Testing
      • Companion Diagnostics
      • Circulating Tumor Cells
    • Abbott Diagnostics (Abbott Park, Illinois)
      • COVID-19
      • Point-of-Care Tests
      • Core Laboratory
      • Molecular Assays
      • Companion Diagnostics
      • Liquid Biopsy
    • Danaher Corporation (Washington, D.C.)
      • Cepheid
      • Radiometer
      • Beckman Coulter
      • Leica Biosystems
    • Thermo Fisher Scientific (Waltham, Massachusetts)
    • Siemens Healthineers (Malvern, Pennsylvania)
    • Becton Dickinson, and Company – BD (Franklin Lakes, New Jersey)
    • bioMérieux (Marcy l’Etoile, France)
    • Illumina (San Diego, California)
    • Ortho Clinical Diagnostics (Raritan, New Jersey)
    • Quidel Corporation (San Diego, California)
    • Exact Sciences (Madison, Wisconsin)
    • Bio-Rad Laboratories (Hercules, California)
    • DiaSorin Group (Saluggia, Italy)
    • Myriad Genetics (Salt Lake City, Utah)
    • Luminex Corporation (Austin, Texas)
  • Chapter 12: Selected Biomarker Compounds (CRP, D-Dimer, PSA, PCT, Others)
    • Immunoglobulins
    • C-Reactive Protein (CRP)
    • D-dimer
    • Prostate-Specific Antigen (PSA)
    • Complement Proteins
    • Cardiac Troponins
    • Albumin/Prealbumin
    • Haptoglobin
    • Procalcitonin (PCT)
    • Lactate
Attachments
The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)
6 Apr 2021

GSL

Request Access

SKU 21-017

Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications.

This report focuses on diagnostics.  The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024, with 2020 as the base year, providing global biomarker market forecasts for the total biomarker market
 
Table of Contents
  • Chapter 1: Introduction
    • Report Coverage
    • Methodology
    • Sources of Information
  • Chapter 2: Executive Summary
  • Chapter 3: Market Environment & Analysis
    • Overview
      • Demographic Patterns
      • World Healthcare Trends
    • Biomarker Technologies
    • Biomarker Market Analysis
      • Biomarker Products
      • Geographical Markets
  • Chapter 4: Infectious Disease Biomarkers
    • Overview
    • Infectious Disease Biomarker Technologies
    • COVID-19 Biomarkers
    • Respiratory Diseases
      • Pneumonia
      • Influenza
      • Group A Streptococcus Infections
      • Tuberculosis
      • Other Respiratory Infections
    • Healthcare-Associated Infections (HAIs)
      • Clostridioides difficile (c. diff)
      • Sepsis
      • Staphylococcus aureus
      • Enterococcus
      • Other Healthcare-Associated Infections
    • Hepatitis
      • Types of Hepatitis
      • Hepatitis Biomarkers
      • Commercial Hepatitis Tests
    • HIV
      • Overview
      • Statistical Trends
      • Biomarker-Based HIV Tests
      • Commercial HIV Tests
    • Sexually Transmitted Diseases (STDs)
      • Human Papillomavirus (HPV)
      • Chlamydia/Gonorrhea (CT/NG)
      • Trichomoniasis
      • Herpes Simplex Virus (HSV-1 & HSV-2)
      • Other Sexually Transmitted Diseases
    • TORCH
    • Other Infectious Diseases
      • Malaria
      • Lyme Disease
      • E. coli
      • H. pylori
      • Dengue
      • All Other Disease
  • Chapter 5: Cancer Biomarkers
    • Overview
    • Types of Cancer Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 6: Cardiovascular Biomarkers
    • Overview
    • Key Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 7: Clinical Chemistry Biomarkers
    • Overview
    • Blood Gases & Electrolytes
    • Urinanalysis
    • Workstation Immunoassay Tests
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 8: Neurological Biomarkers
    • Overview
    • Key Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 9: Autoimmune Biomarkers
    • Overview
    • Key Biomarkers
    • Market Analysis
    • Biomarker Product Suppliers
  • Chapter 10: Other Biomarkers
    • Overview
    • Diabetes & Metabolic Biomarkers
    • Fertility & Pregnancy Biomarkers
    • Kidney Disorders
    • Inherited Diseases
      • Cystic Fibrosis
      • Down Syndrome
      • Sickle Cell Disease
      • Gaucher Disease
      • Familial Hypercholesterolemia
      • Muscular Dystrophy
      • Hemophilia
      • Von Willebrand Disease
      • Neurofibromatosis
      • Polycystic Kidney Disease
      • Spinal Muscle Atrophy
      • Klinefelter Syndrome
      • Canavan disease
      • Cerebral Palsy
      • Angelman Syndrome (AS)
      • Other Inherited Diseases
    • Thyroid Conditions
    • All Other Biomarkers
      • Bone Disease Biomarkers
      • Gastrointestinal Biomarkers
      • Respiratory Biomarkers
  • Chapter 11: Company Profiles
    • Roche Diagnostics (Basel, Switzerland)
      • Molecular Testing
      • Companion Diagnostics
      • Circulating Tumor Cells
    • Abbott Diagnostics (Abbott Park, Illinois)
      • COVID-19
      • Point-of-Care Tests
      • Core Laboratory
      • Molecular Assays
      • Companion Diagnostics
      • Liquid Biopsy
    • Danaher Corporation (Washington, D.C.)
      • Cepheid
      • Radiometer
      • Beckman Coulter
      • Leica Biosystems
    • Thermo Fisher Scientific (Waltham, Massachusetts)
    • Siemens Healthineers (Malvern, Pennsylvania)
    • Becton Dickinson, and Company – BD (Franklin Lakes, New Jersey)
    • bioMérieux (Marcy l’Etoile, France)
    • Illumina (San Diego, California)
    • Ortho Clinical Diagnostics (Raritan, New Jersey)
    • Quidel Corporation (San Diego, California)
    • Exact Sciences (Madison, Wisconsin)
    • Bio-Rad Laboratories (Hercules, California)
    • DiaSorin Group (Saluggia, Italy)
    • Myriad Genetics (Salt Lake City, Utah)
    • Luminex Corporation (Austin, Texas)
  • Chapter 12: Selected Biomarker Compounds (CRP, D-Dimer, PSA, PCT, Others)
    • Immunoglobulins
    • C-Reactive Protein (CRP)
    • D-dimer
    • Prostate-Specific Antigen (PSA)
    • Complement Proteins
    • Cardiac Troponins
    • Albumin/Prealbumin
    • Haptoglobin
    • Procalcitonin (PCT)
    • Lactate
Categories
To the Top
More information about this product
Table of Contents
Other Users Also Viewed
IVD Procedure Volumes 2020-2025
26 Feb 2021
SKU 21-015 In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test…
The World Market for Molecular Diagnostics Tests, 10th Edition (NGS, PCR, NAAT, ISH, TMA, Other)
18 Jun 2021
The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
25 Aug 2021
Molecular Cancer Diagnostics Market
12 Feb 2020
United States Market for In Vitro Diagnostic (IVD) Tests
7 Jun 2021